Terms: = Prostate cancer AND CCDC6, D10S170, 8030, ENSG00000108091, Q16204, TPC, H4, TST1
112 results:
1. Epigenetic underpinnings of tumor-immune dynamics in prostate cancer immune suppression.
Angappulige DH; Mahajan NP; Mahajan K
Trends Cancer; 2024 Apr; 10(4):369-381. PubMed ID: 38341319
[TBL] [Abstract] [Full Text] [Related]
2. Using Behavioral Economics to Reduce Low-Value Care Among Older Adults: A Cluster Randomized Clinical Trial.
Kullgren JT; Kim HM; Slowey M; Colbert J; Soyster B; Winston SA; Ryan K; Forman JH; Riba M; Krupka E; Kerr EA
JAMA Intern Med; 2024 Mar; 184(3):281-290. PubMed ID: 38285565
[TBL] [Abstract] [Full Text] [Related]
3. Human cancer Cell Radiation Response Investigated through Topological Analysis of 2D Cell Networks.
Tirinato L; Onesto V; Garcia-Calderon D; Pagliari F; Spadea MF; Seco J; Gentile F
Ann Biomed Eng; 2023 Aug; 51(8):1859-1871. PubMed ID: 37093401
[TBL] [Abstract] [Full Text] [Related]
4. A first-in-class HBO1 inhibitor WM-3835 inhibits castration-resistant prostate cancer cell growth in vitro and in vivo.
Mi YY; Ji Y; Zhang L; Sun CY; Wei BB; Yang DJ; Wan HY; Qi XW; Wu S; Zhu LJ
Cell Death Dis; 2023 Jan; 14(1):67. PubMed ID: 36709328
[TBL] [Abstract] [Full Text] [Related]
5. Glyphosate disturbs various epigenetic processes in vitro and in vivo - A mini review.
Bukowska B; Woźniak E; Sicińska P; Mokra K; Michałowicz J
Sci Total Environ; 2022 Dec; 851(Pt 2):158259. PubMed ID: 36030868
[TBL] [Abstract] [Full Text] [Related]
6. LINC00839 promotes colorectal cancer progression by recruiting RUVBL1/Tip60 complexes to activate NRF1.
Liu X; Chen J; Zhang S; Liu X; Long X; Lan J; Zhou M; Zheng L; Zhou J
EMBO Rep; 2022 Sep; 23(9):e54128. PubMed ID: 35876654
[TBL] [Abstract] [Full Text] [Related]
7. Identification of fusions with potential clinical significance in melanoma.
Moran JMT; Le LP; Nardi V; Golas J; Farahani AA; Signorelli S; Onozato ML; Foreman RK; Duncan LM; Lawrence DP; Lennerz JK; Dias-Santagata D; Hoang MP
Mod Pathol; 2022 Dec; 35(12):1837-1847. PubMed ID: 35871080
[TBL] [Abstract] [Full Text] [Related]
8. prostate health index (PHI) as a reliable biomarker for prostate cancer: a systematic review and meta-analysis.
Agnello L; Vidali M; Giglio RV; Gambino CM; Ciaccio AM; Lo Sasso B; Ciaccio M
Clin Chem Lab Med; 2022 Jul; 60(8):1261-1277. PubMed ID: 35567430
[TBL] [Abstract] [Full Text] [Related]
9. Lithocholic acid-tryptophan conjugate (UniPR126) based mixed micelle as a nano carrier for specific delivery of niclosamide to prostate cancer via EphA2 receptor.
Jannu AK; Puppala ER; Gawali B; Syamprasad NP; Alexander A; Marepally S; Chella N; Gangasani JK; Naidu VGM
Int J Pharm; 2021 Aug; 605():120819. PubMed ID: 34166727
[TBL] [Abstract] [Full Text] [Related]
10. Immune Checkpoints, Inhibitors and Radionuclides in prostate cancer: Promising Combinatorial Therapy Approach.
Kgatle MM; Boshomane TMG; Lawal IO; Mokoala KMG; Mokgoro NP; Lourens N; Kairemo K; Zeevaart JR; Vorster M; Sathekge MM
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921181
[TBL] [Abstract] [Full Text] [Related]
11. Sulforaphane Reduces prostate cancer Cell Growth and Proliferation In Vitro by Modulating the Cdk-Cyclin Axis and Expression of the CD44 Variants 4, 5, and 7.
Rutz J; Thaler S; Maxeiner S; Chun FK; Blaheta RA
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33218199
[TBL] [Abstract] [Full Text] [Related]
12. Epigenetic modification-dependent androgen receptor occupancy facilitates the ectopic TSPY1 expression in prostate cancer cells.
Leng X; Liu M; Tao D; Yang B; Zhang Y; He T; Xie S; Wang Z; Liu Y; Yang Y
Cancer Sci; 2021 Feb; 112(2):691-702. PubMed ID: 33185915
[TBL] [Abstract] [Full Text] [Related]
13. LPCAT1 enhances castration resistant prostate cancer progression via increased mRNA synthesis and PAF production.
Han C; Yu G; Mao Y; Song S; Li L; Zhou L; Wang Z; Liu Y; Li M; Xu B
PLoS One; 2020; 15(11):e0240801. PubMed ID: 33137125
[TBL] [Abstract] [Full Text] [Related]
14. Dracocephalum palmatum Stephan extract induces apoptosis in human prostate cancer cells via the caspase-8-mediated extrinsic pathway.
Lee SE; Okhlopkova Z; Lim C; Cho S
Chin J Nat Med; 2020 Oct; 18(10):793-800. PubMed ID: 33039058
[TBL] [Abstract] [Full Text] [Related]
15. Inflammatory markers as prognostic factors in metastatic castration-resistant prostate cancer.
Donate-Moreno MJ; Lorenzo-Sánchez MV; Díaz de Mera-Sánchez Migallón I; Herraiz-Raya L; Esper-Rueda JA; Legido-Gómez O; Rico-Marco S; Salinas-Sánchez AS
Actas Urol Esp (Engl Ed); 2020 Dec; 44(10):692-700. PubMed ID: 33010988
[TBL] [Abstract] [Full Text] [Related]
16. GC-MS analysis, antimicrobial, antioxidant, antilipoxygenase and cytotoxic activities of Jacaranda mimosifolia methanol leaf extracts and fractions.
Naz R; Roberts TH; Bano A; Nosheen A; Yasmin H; Hassan MN; Keyani R; Ullah S; Khan W; Anwar Z
PLoS One; 2020; 15(7):e0236319. PubMed ID: 32726328
[TBL] [Abstract] [Full Text] [Related]
17. Preclinical anticancer studies on the ethyl acetate leaf extracts of Datura stramonium and Datura inoxia.
Nasir B; Baig MW; Majid M; Ali SM; Khan MZI; Kazmi STB; Haq IU
BMC Complement Med Ther; 2020 Jun; 20(1):188. PubMed ID: 32552791
[TBL] [Abstract] [Full Text] [Related]
18. Role of class I histone deacetylases in the regulation of maspin expression in prostate cancer.
Shankar E; Pandey M; Verma S; Abbas A; Candamo M; Kanwal R; Shukla S; MacLennan GT; Gupta S
Mol Carcinog; 2020 Aug; 59(8):955-966. PubMed ID: 32391971
[TBL] [Abstract] [Full Text] [Related]
19. B7-H4 is a potential prognostic biomarker of prostate cancer.
Li H; Piao L; Liu S; Cui Y; Xuan Y
Exp Mol Pathol; 2020 Jun; 114():104406. PubMed ID: 32088189
[TBL] [Abstract] [Full Text] [Related]
20. Distinct tumor microenvironments of lytic and blastic bone metastases in prostate cancer patients.
Ihle CL; Provera MD; Straign DM; Smith EE; Edgerton SM; Van Bokhoven A; Lucia MS; Owens P
J Immunother Cancer; 2019 Nov; 7(1):293. PubMed ID: 31703602
[TBL] [Abstract] [Full Text] [Related]
[Next]